Genesis Medtech Group Raises Significant Growth Investment in Latest Round of Series B Financing
SINGAPORE, May 25, 2021 - (ACN Newswire) - Genesis MedTech Group ("Genesis"), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing.
- SINGAPORE, May 25, 2021 - (ACN Newswire) - Genesis MedTech Group ("Genesis"), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing.
- Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors.
- This latest round of funding will enable Genesis to continue to tackle disparities in medtech accessibility across global markets.
- Genesis MedTech Group covers the entire industry value chain of research and development, production, quality management, supply chain, marketing, and sales.